Safety and Effectiveness of Carbon Dioxide Contrast Medium in Infra-Inguinal Endovascular Interventions for Patients With Chronic Threatening Lower Limb Ischemia and Renal Impairment: A Multicentric Trial.

IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Journal of Endovascular Therapy Pub Date : 2024-10-01 Epub Date: 2023-03-16 DOI:10.1177/15266028231159241
Mohamed Ali, Mohamed Noureldin, Omar El Kashef, Hossam Zaghlol
{"title":"Safety and Effectiveness of Carbon Dioxide Contrast Medium in Infra-Inguinal Endovascular Interventions for Patients With Chronic Threatening Lower Limb Ischemia and Renal Impairment: A Multicentric Trial.","authors":"Mohamed Ali, Mohamed Noureldin, Omar El Kashef, Hossam Zaghlol","doi":"10.1177/15266028231159241","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess the safety and effectiveness of using carbon dioxide (CO<sub>2</sub>) contrast in both supra- and infra-genicular endovascular interventions in patients with renal impairment.</p><p><strong>Material and methods: </strong>This is a multicentric prospective observational study conducted over a period of 3 years from 2017 to 2020; the study included 114 patients presented with chronic threatening limb ischemia (CTLI) and renal impairment (lowest serum creatinine levels ≥1.3 mg/dL) for whom endovascular procedures were done using CO<sub>2</sub> as a contrast medium. Endovascular angiography was guided by CO<sub>2</sub> either exclusively (zero contrast) or with the aid of small amount of supplementary iodinated contrast media (ICM) injections. The qualitative assessment of the angiographic images in both supra- and infra-genicular fields were reported and scaled.</p><p><strong>Results: </strong>The qualitative diagnostic images were excellent in 86.5% in the supra-genicular and 66.5% in infra-genicular images. There were no significant changes in mean serum creatinine levels from baseline to first and fifth days post procedural (mean 1.8 mg/dL vs mean 1.9 mg/dL and mean 1.7 mg/dL).</p><p><strong>Conclusion: </strong>CO<sub>2</sub> is a non-nephrotoxic alternative to traditional ICM that could be safely used and well tolerated during endovascular interventions for peripheral arterial disease in patients with renal impairment. Primary safety and efficacy endpoints were achieved in 100% of cases. The use of automated injector system provides adequate delivery, optimizes the dose, and avoids air contamination. For infra-genicular segment opacification, we recommend super-selective injections and some changes in angiographic techniques from contrast preparation to image post-processing.</p><p><strong>Clinical impact: </strong>Co<sub>2</sub> is a non-nephrotoxic alternative to traditional ICM that could be safely used and well tolerated during peripheral endovascular interventions in patients with renal impairment. The use of automated injector system would provide adequate delivery, optimizes the dose and avoids air contamination. For infra-genicular segment opacification, its recommended to use selective injection as close to the target artery as possible and some changes in angiographic techniques from contrast preparation to image post-processing.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028231159241","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/3/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To assess the safety and effectiveness of using carbon dioxide (CO2) contrast in both supra- and infra-genicular endovascular interventions in patients with renal impairment.

Material and methods: This is a multicentric prospective observational study conducted over a period of 3 years from 2017 to 2020; the study included 114 patients presented with chronic threatening limb ischemia (CTLI) and renal impairment (lowest serum creatinine levels ≥1.3 mg/dL) for whom endovascular procedures were done using CO2 as a contrast medium. Endovascular angiography was guided by CO2 either exclusively (zero contrast) or with the aid of small amount of supplementary iodinated contrast media (ICM) injections. The qualitative assessment of the angiographic images in both supra- and infra-genicular fields were reported and scaled.

Results: The qualitative diagnostic images were excellent in 86.5% in the supra-genicular and 66.5% in infra-genicular images. There were no significant changes in mean serum creatinine levels from baseline to first and fifth days post procedural (mean 1.8 mg/dL vs mean 1.9 mg/dL and mean 1.7 mg/dL).

Conclusion: CO2 is a non-nephrotoxic alternative to traditional ICM that could be safely used and well tolerated during endovascular interventions for peripheral arterial disease in patients with renal impairment. Primary safety and efficacy endpoints were achieved in 100% of cases. The use of automated injector system provides adequate delivery, optimizes the dose, and avoids air contamination. For infra-genicular segment opacification, we recommend super-selective injections and some changes in angiographic techniques from contrast preparation to image post-processing.

Clinical impact: Co2 is a non-nephrotoxic alternative to traditional ICM that could be safely used and well tolerated during peripheral endovascular interventions in patients with renal impairment. The use of automated injector system would provide adequate delivery, optimizes the dose and avoids air contamination. For infra-genicular segment opacification, its recommended to use selective injection as close to the target artery as possible and some changes in angiographic techniques from contrast preparation to image post-processing.

二氧化碳造影剂在慢性下肢缺血和肾功能受损患者静脉腔内血管介入治疗中的安全性和有效性:一项多中心试验。
目的:评估在肾功能受损患者的肾上和肾下血管内介入治疗中使用二氧化碳(CO2)造影剂的安全性和有效性:这是一项多中心前瞻性观察研究,从2017年至2020年进行,为期3年;研究纳入了114例慢性威胁性肢体缺血(CTLI)和肾功能损害(最低血清肌酐水平≥1.3 mg/dL)患者,这些患者使用二氧化碳作为造影剂进行血管内介入手术。血管内造影完全以二氧化碳为造影剂(零造影剂),或辅以少量碘化造影剂(ICM)注射。对血管造影图像进行了定性评估,包括血管上和血管下视野,并按比例进行了报告:结果:86.5%的根管上和 66.5%的根管下血管造影图像的定性诊断结果为优秀。从基线到术后第一天和第五天,平均血清肌酐水平无明显变化(平均 1.8 mg/dL vs 平均 1.9 mg/dL 和平均 1.7 mg/dL):二氧化碳是传统 ICM 的一种无肾毒性替代品,可在肾功能受损患者的外周动脉疾病血管内介入治疗中安全使用,且耐受性良好。100%的病例都达到了主要的安全性和有效性终点。使用自动注射系统可提供充分的给药,优化剂量并避免空气污染。对于肾下段不透明,我们建议进行超选择性注射,并对血管造影技术(从对比剂准备到图像后期处理)进行一些改动:临床影响:Co2 是传统 ICM 的无肾毒性替代品,可在肾功能受损患者的外周血管介入治疗中安全使用,且耐受性良好。使用自动注射系统可提供充足的给药量,优化剂量并避免空气污染。对于肾动脉下段不透明,建议使用选择性注射,尽可能靠近目标动脉,并对造影剂制备和图像后处理等血管造影技术进行一些改动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
15.40%
发文量
203
审稿时长
6-12 weeks
期刊介绍: The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信